Dear Sir, Rheumatic fever (RF) has been linked with the presence of antiphospholipid syndrome [1] , especially with antiphospholipid antibodies, represented by anticardiolipin in 40% of the patients [2] and anti-2-glicoprotein I antibodies in 24% of them [3] . However, there is no study in which all routine antiphospholipid antibodies were performed simultaneously in RF patients. Consequently, the objective of this study was to evaluate the frequency and clinical signiWcance of three routine antiphospholipid antibodies in sera from patients with RF who had cardiac involvement.
All study participants met the modiWed Jones criteria for the diagnosis of RF [4] . This research is characterized as a descriptive cross-sectional study that was conducted in the Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo. The data regarding laboratory results from all 9 RF patients were obtained from the patients' medical Wles. Using standard techniques, serum samples were tested for lupus anticoagulant (functional tests), IgM and IgG anticardiolipin (ELISA), and IgM and IgG anti-2-GPI (ELISA) [5, 6] .
Mean age of RF patients was 23.9 § 6.8 years; 56% were women and 67% Caucasian race. Mean disease duration was 10.8 § 6.9 years. All patients had cardiac lesions, with 100% of mitral involvement. Polyarthritis was observed in 67% and chorea in 34%. In contrast to other studies, no patient had any sera positive for antiphospholipid antibodies such as IgG or IgM anticardiolipin, lupus anticoagulant, and IgG or IgM anti-2-GPI analyzed.
We were not able to demonstrate a relationship between antiphospholipid antibodies in RF patients who had cardiac involvement. Figueroa et al. [2] have shown that during active phase of RF, 80% of patients have positivity for anticardiolipin, while during inactive disease, only 40% have had these autoantibodies. Therefore, due to the absence of these antibodies in sera from our 9 patients with long-term RF, it is reasonable to speculate that diVerent phases of this disease such as the acute phase may induce the appearance of these antibodies as previously demonstrated [2] .
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